Introducing EbolaCheck: potential for point-of-need infectious disease diagnosis


Autoria(s): Moschos, S
Data(s)

31/08/2015

Resumo

The 2013–2015 Ebolavirus disease humanitarian crisis has spurred the development of laboratory-free, point-of-care nucleic acid testing solutions. EbolaCheck is an international consortium of public health, academic and biotechnology industry stakeholders aiming to deliver clinical molecular diagnostic standard-of-care testing suitable for the West African milieu within 12 months. In this article, the current status of the EbolaCheck platform is discussed in the context of the current regulatory framework. Presented here are future goals to achieve differential diagnosis of hemorrhagic fever disease from <5-μl of whole blood samples or mucosal biofluids, in a single tube process, under 40 min and with minimal operator training requirements.

Formato

application/pdf

Identificador

http://westminsterresearch.wmin.ac.uk/16213/1/Moschos_2015_accepted_author_manuscript.pdf

Moschos, S (2015) Introducing EbolaCheck: potential for point-of-need infectious disease diagnosis. Expert Review of Molecular Diagnostics, 15 (10). pp. 1237-1240. ISSN 1473-7159

Idioma(s)

en

Publicador

Informa Healthcare

Relação

http://westminsterresearch.wmin.ac.uk/16213/

https://dx.doi.org/10.1586/14737159.2015.1084228

10.1586/14737159.2015.1084228

Palavras-Chave #Science and Technology
Tipo

Article

PeerReviewed